← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Gaia Medical Institute, Inc.
La Jolla, CA
$8,745,667
Total funding
8
Grants
Funding over time
peak $2.1M · FY2010–23$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,494,388 · 6
DOD$1,026,279 · 1
CDC$225,000 · 1
By mechanism
R44$6,698,978 · 4
—$1,026,279 · 1
R43$1,020,410 · 3
Investigators at Gaia Medical Institute, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Rapid saliva test for noninvasive diagnostic screening of MCI and dementia$1,302,154
R44 · FY2023 · AG
Rapid saliva test for noninvasive diagnostic screening of MCI and dementia$1,282,078
R44 · FY2022 · AG
BIOMARKERS FOR NONINVASIVE ASSESSMENT OF HUMAN HYDRATION STATUS$1,026,279
· FY2010 · Department of Defense
Rapid saliva test for diagnosis of mTBI and prognosis of Persistent Post-conccussion Symptoms (PPCS) in children and adults$865,950
R44 · FY2021 · HD
Rapid saliva test for diagnosis of mTBI and prognosis of Persistent Post-conccussion Symptoms (PPCS) in children and adults$832,833
R44 · FY2022 · HD
Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT)$736,575
R44 · FY2018 · HD
Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT)$708,335
R44 · FY2017 · HD
Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients$442,248
R43 · FY2011 · DE
NEXT-GEN Oral test for monitoring HIV/AIDS in Point-of-Care$434,121
R44 · FY2016 · DE
NEXT-GEN Oral test for monitoring HIV/AIDS in Point-of-Care$374,022
R44 · FY2017 · DE
Saliva biomarkers for noninvasive diagnostics of acute mTBI in children$298,862
R43 · FY2018 · HD
Saliva biomarkers for predicting outcome in pediatric and adult patients with severe and moderate TBI$225,000
R43 · FY2018 · CE
Rapid oral test for Influenza A+B diagnostics$162,910
R44 · FY2018 · DE
Saliva biomarkers for noninvasive diagnostics of acute mTBI in children$54,300
R43 · FY2020 · HD